Shades of white: diffusion properties of T1- and FLAIR-defined white matter signal abnormalities differ in stages from cognitively normal to dementia

• Published in: Neurobiology of aging Vol. 68; pp. 48 - 58
• Main Authors: Riphagen, Joost M., Gronenschild, Ed H.B.M., Salat, David H., Freeze, Whitney M., Ivanov, Dimo, Clerx, Lies, Verhey, Frans R.J., Aalten, Pauline, Jacobs, Heidi I.L.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2018
• Subjects: Aging; Alzheimer's disease; Diffusion tensor imaging; MRI; White matter; White matter hyper intensities; Aging; MRI; White matter; Alzheimer's disease; White matter hyper intensities; Diffusion tensor imaging
• ISSN: 0197-4580; 1558-1497
• DOI: 10.1016/j.neurobiolaging.2018.03.029

The underlying pathology of white matter signal abnormalities (WMSAs) is heterogeneous and may vary dependent on the magnetic resonance imaging contrast used to define them. We investigated differences in white matter diffusivity as an indicator for white matter integrity underlying WMSA based on T1-weighted and fluid-attenuated inversion recovery (FLAIR) imaging contrast. In addition, we investigated which white matter region of interest (ROI) could predict clinical diagnosis best using diffusion metrics. One hundred three older individuals with varying cognitive impairment levels were included and underwent neuroimaging. Diffusion metrics were extracted from WMSA areas based on T1 and FLAIR contrast and from their overlapping areas, the border surrounding the WMSA and the normal-appearing white matter (NAWM). Regional diffusivity differences were calculated with linear mixed effects models. Multinomial logistic regression determined which ROI diffusion values classified individuals best into clinically defined diagnostic groups. T1-based WMSA showed lower white matter integrity compared to FLAIR WMSA-defined regions. Diffusion values of NAWM predicted diagnostic group best compared to other ROI's. To conclude, T1- or FLAIR-defined WMSA provides distinct information on the underlying white matter integrity associated with cognitive decline. Importantly, not the “diseased” but the NAWM is a potentially sensitive indicator for cognitive brain health status.